Furthermore, even if the only difference between a nano-sized
invention and the prior art is with respect to its dimensions, then
non-obviousness may still be established if the prior art does not teach
and/or enable one to make the nanoscale version without undue
experimentation. This important principle of law was established by the
Courts in In re Hoeksema in which a claim to a chemical compound was
rejected by an examiner because its structure was already suggested by
the prior art. In disagreement, the Court held that even though the
structure may have been suggested, the claimed chemical compound may
nevertheless be non-obvious if before the application was filed, no
process existed to enable its production. Therefore, if the prior art
fails to provide enablement for making a nano-sized invention, then
non-obviousness could be established on the basis of size alone.
Sufficient disclosure
A patent application must describe how to make and use the
invention without undue experimentation. If the patent application fails
to meet these criteria, then either no patent will issue or the claims
will have to be narrowed to correspond to the level of enablement
supported by the application. In a traditional and predictable
technology, such as chemical engineering, procedures for performing
various techniques are usually well known and developed, standardized,
and reproducible. Thus, the requirement for an enabling disclosure is
more easily met for inventions derived from such technologies since less
information and examples need to be provided in the application to make
and use the invention. The knowledge of one skilled in the art can also
be relied upon to fill in any gaps missing from an application to
satisfy these legal requirements. However, since nanotechnology
typically embraces multiple scientific disciplines, it may likely be
less predictable and able to rely on prior art techniques and a few
examples to support broad claims in an application.
Furthermore, in the U.S., the inventor is expected to comply with
the "best mode requirement" by describing the preferred
embodiment or optimal means of practicing the claimed invention if it
materially affects the properties of the invention. If specific
techniques or instruments were developed for building a nanoscale
invention that were recognized by the inventor as the best way of
carrying out the invention at the time the application was filed, then
the best mode requirement further imposes an obligation to disclose that
information to the public.
Clearly, the extent of disclosure sufficient to satisfy
patentability will require careful consideration in drafting a
nanotechnology-related application if the broadest available patent
protection is sought.
Although the interdisciplinary nature of nanotechnology fosters
creative new approaches to solving problems peculiar to a research
focus, drafting applications for such inventions will require thorough
consideration to avoid potential pitfalls in patent prosecution. It is
therefore important that an inventor and/or patentee carefully consider
how patentability requirements will be applied to nanotechnology and
actively involve themselves with their patent practitioner to ensure
that their ideas are properly protected. Since the primary difference
between a nano-sized invention and its larger-scaled counterpart is
typically its size/dimensions, it is particularly important to make
clear that the invention constitutes more than a mere miniaturization of
known materials and methods. Placing emphasis on how it performs
differently, or yields a different useful result from the prior art is
key to establishing patentability.
Elizabeth Hayes is an associate with the intellectual property law
firm of Smart & Biggar/Fethertonhaugh and is a qualified U.S. and
Canadian patent agent. Hayes obtained her MEng in biomedical engineering
at McGill University, where she acquired a knowledge base in blood
physiology, colloid/polymer chemistry, and immobilization technology due
to the interdisciplinary nature of her research work.
COPYRIGHT 2007 Chemical Institute of
Canada Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.